- Home
- INBX vs SITC Comparison
INBX vs SITC Comparison
Compare INBX & SITC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- SITC
- Stock Information
- Founded
- INBX 2010
- SITC 1965
- Country
- INBX United States
- SITC United States
- Employees
- INBX N/A
- SITC N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- SITC Real Estate Investment Trusts
- Sector
- INBX Health Care
- SITC Real Estate
- Exchange
- INBX Nasdaq
- SITC Nasdaq
- Market Cap
- INBX 430.2M
- SITC 461.0M
- IPO Year
- INBX 2020
- SITC 1993
- Fundamental
- Price
- INBX $78.51
- SITC $8.38
- Analyst Decision
- INBX Hold
- SITC Hold
- Analyst Count
- INBX 2
- SITC 4
- Target Price
- INBX N/A
- SITC $13.13
- AVG Volume (30 Days)
- INBX 680.2K
- SITC 924.2K
- Earning Date
- INBX 11-14-2025
- SITC 11-05-2025
- Dividend Yield
- INBX N/A
- SITC 68.62%
- EPS Growth
- INBX N/A
- SITC N/A
- EPS
- INBX N/A
- SITC 6.74
- Revenue
- INBX $1,400,000.00
- SITC $173,351,000.00
- Revenue This Year
- INBX $563.00
- SITC N/A
- Revenue Next Year
- INBX $230.77
- SITC N/A
- P/E Ratio
- INBX N/A
- SITC $1.20
- Revenue Growth
- INBX N/A
- SITC N/A
- 52 Week Low
- INBX $10.81
- SITC $8.35
- 52 Week High
- INBX $83.78
- SITC $16.97
- Technical
- Relative Strength Index (RSI)
- INBX 84.62
- SITC 34.34
- Support Level
- INBX $28.16
- SITC $8.68
- Resistance Level
- INBX $39.27
- SITC $8.91
- Average True Range (ATR)
- INBX 5.72
- SITC 0.19
- MACD
- INBX 4.49
- SITC 0.02
- Stochastic Oscillator
- INBX 90.52
- SITC 5.79
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.